• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.01%

    Elite Pharmaceuticals, Inc. (ELTP)

    -OTC BB
    0.24 Up 0.00(1.29%) Jul 31, 3:59PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Mar 31, 2014Mar 31, 2013
    Total Revenue 5,015   4,601   3,404  
    Cost of Revenue3,014  3,236  2,315  
    Gross Profit 2,002   1,365   1,088  
    Operating Expenses
    Research Development14,727  3,959  975  
    Selling General and Administrative3,164  2,189  1,559  
    Non Recurring -   -   -  
    Others617  501  117  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (16,507) (5,284) (1,563)
    Income from Continuing Operations
    Total Other Income/Expenses Net45,721  (90,684)3,090  
    Earnings Before Interest And Taxes29,214  (95,968)1,527  
    Interest Expense287  900  393  
    Income Before Tax28,926  (96,868)1,134  
    Income Tax Expense(3)(293)(354)
    Minority Interest -   -   -  
    Net Income From Continuing Ops28,930  (96,575)1,488  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 28,930   (96,575) 1,488  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 28,930   (96,575) 1,488  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.